Gaur Abhay Singh, Tarigopula Vivek, Mandal Swarnendu, Ayyanar Pavithra, Purkait Suvendu, Singh Kirti, Sabique C, Nayak Prasant
Department of Urology, All India Institute of Medical Sciences, Bathinda, Punjab, India.
Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Indian J Urol. 2025 Apr-Jun;41(2):131-136. doi: 10.4103/iju.iju_519_24. Epub 2025 Apr 1.
The minced buccal mucosal graft endourethral urethroplasty (MBGEU) is our novel technique of combining direct vision internal urethrotomy with buccal mucosal graft urethroplasty. We assessed success at 30-months of follow-up. Secondary objectives were to compare the changes in the American Urological Association (AUA) symptom score, peak flow rate (Qmax), and post-void residue (PVR) postoperatively.
This pilot study (CTRI/2021/09/036651) was conducted at a tertiary-care center and included 30 male patients with primary, <2 cm bulbar urethral strictures. A 1 cm × 1 cm buccal mucosal graft was harvested, minced, centrifuged, and suspended in fibrin glue. After a cold knife urethrotomy, a 12-Fr Foley was placed. An 11-Fr cystourethroscope was passed by the side of the catheter, and the suspension was instilled through a 5-Fr ureteric catheter over the urethrotomy site.
The success rate of MBGEU was 93.33% at 12 months, 90% at 18 months, 83.3% at 24 months, and 76.6% at 30 months. The stricture recurred in seven patients. The AUA score reduced by 15, 15, 16, 16, 15.5, and 15.5 points from the baseline at 3, 6, 12, 18, 24, and 30 months (P < 0.01). There was a significant increase in the Qmax by 17 ml/s and a significant reduction in the PVR by 73.5 ml at 30 months (P < 0.01). No donor site morbidity was seen. There were no postoperative complications.
The medium-term success of MBGEU is encouraging. However, a longer follow-up and further studies with a larger sample size and a comparative arm are required.
切碎的颊黏膜移植尿道内尿道成形术(MBGEU)是我们将直视下内切开术与颊黏膜移植尿道成形术相结合的新技术。我们评估了30个月随访期的成功率。次要目标是比较术后美国泌尿外科学会(AUA)症状评分、最大尿流率(Qmax)和残余尿量(PVR)的变化。
这项前瞻性研究(CTRI/2021/09/036651)在一家三级医疗中心进行,纳入了30例患有原发性、<2 cm球部尿道狭窄的男性患者。获取一块1 cm×1 cm的颊黏膜移植片,切碎、离心,然后悬浮于纤维蛋白胶中。在冷刀尿道内切开术后,置入一根12 Fr的Foley导尿管。通过导尿管旁插入一根11 Fr的膀胱尿道镜,通过一根5 Fr的输尿管导管将悬浮液注入尿道切开部位上方。
MBGEU的成功率在12个月时为93.33%,18个月时为90%,24个月时为83.3%,30个月时为76.6%。7例患者狭窄复发。AUA评分在3、6、12、18、24和30个月时较基线分别降低了15、15、16、16、15.5和15.5分(P<0.01)。30个月时Qmax显著增加17 ml/s,PVR显著减少73.5 ml(P<0.01)。未观察到供区并发症。无术后并发症。
MBGEU的中期成功率令人鼓舞。然而,需要更长时间的随访以及更大样本量和设有对照臂的进一步研究。